NEW YORK (GenomeWeb News) – Link Technologies has licensed Agilent Technologies' RNA monomers technology, the Scottish company said today.
Link Technologies said it will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.
The company makes reagents for oligonucleotide synthesis and modification, and it offers a variety of products including phosphoramidites, solid supports, modifiers, labels, bioconjugation and oligo-immobilisation products.
Financial terms of the agreement were not released.